Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MAQ-001 by MabQuest for Solid Tumor: Likelihood of Approval
MAQ-001 is under clinical development by MabQuest and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...